Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HOB Biotech is a leading Chinese in vitro diagnostics company specializing in allergy and autoimmune disease testing. It has commercialized multiple diagnostic platforms globally and is the market leader in China’s allergy/autoimmune diagnostics segment. The company also has a biopharmaceutical R&D arm with five major drug candidates targeting oncology and autoimmunity—two are in Phase III trials as of late 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HOB Biotech Group.